Cargando…

RARRES2 regulates lipid metabolic reprogramming to mediate the development of brain metastasis in triple negative breast cancer

BACKGROUND: Triple negative breast cancer (TNBC), the most aggressive subtype of breast cancer, is characterized by a high incidence of brain metastasis (BrM) and a poor prognosis. As the most lethal form of breast cancer, BrM remains a major clinical challenge due to its rising incidence and lack o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yi-Qun, Sun, Fang-Zhou, Li, Chun-Xiao, Mo, Hong-Nan, Zhou, Yan-Tong, Lv, Dan, Zhai, Jing-Tong, Qian, Hai-Li, Ma, Fei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369725/ https://www.ncbi.nlm.nih.gov/pubmed/37491281 http://dx.doi.org/10.1186/s40779-023-00470-y

Ejemplares similares

RARRES2’s impact on lipid metabolism in triple-negative breast cancer: a pathway to brain metastasis
por: Shubhra, Quazi T. H.
Publicado: (2023)

RARRES3 suppresses breast cancer lung metastasis by regulating adhesion and differentiation
por: Morales, Mònica, et al.
Publicado: (2014)

β→LACTAMASE-PRODUCING ANAEROBES
por: Reilly, Sheena, et al.
Publicado: (1980)

The metastasis suppressor RARRES3 as an endogenous inhibitor of the immunoproteasome expression in breast cancer cells
por: Anderson, Alison M., et al.
Publicado: (2017)

Metabolic Reprogramming in Triple-Negative Breast Cancer
por: Sun, Xiangyu, et al.
Publicado: (2020)

Retinoic acid represses invasion and stem cell phenotype by induction of the metastasis suppressors RARRES1 and LXN
por: Oldridge, E E, et al.
Publicado: (2013)

Metabolic reprogramming in triple-negative breast cancer
por: Wang, Zhanyu, et al.
Publicado: (2020)

Tumour Necrosis Factor-α Gene Polymorphism Is Associated with Metastasis in Patients with Triple Negative Breast Cancer
por: Li, Hui-Hui, et al.
Publicado: (2015)

TGF-β induced reprogramming and drug resistance in triple-negative breast cells
por: Wu, Guoyu, et al.
Publicado: (2022)

RARRES3 expression positively correlated to tumour differentiation in tissues of colorectal adenocarcinoma
por: Shyu, R-Y, et al.
Publicado: (2003)

Multiple roles of RARRES1 in prostate cancer: Autophagy induction and angiogenesis inhibition
por: Roy, Arpita, et al.
Publicado: (2017)

RARRES3 regulates signal transduction through post-translational protein modifications
por: Hsu, Tzu-Hui, et al.
Publicado: (2015)

Expression of RARRES1 and AGBL2 and progression of conventional renal cell carcinoma
por: Peterfi, Lehel, et al.
Publicado: (2020)

Association of Polymorphisms in STRA6 and RARRES2 Genes with Type 2 Diabetes in Southern Han Chinese
por: Huang, Han-Wei, et al.
Publicado: (2016)

Loss of RARRES1 function Promotes Follicular Lymphomagenesis and Inhibits B cell Differentiation in Mice
por: Patel, Jay, et al.
Publicado: (2022)

Search for the Standard Model Higgs boson in the H → WW → ℓνℓν decay mode with 4.7 fb<sup>−1</sup> of ATLAS data at sqrt(s) = 7 TeV
por: The ATLAS collaboration
Publicado: (2012)

Sulforaphane suppresses metastasis of triple-negative breast cancer cells by targeting the RAF/MEK/ERK pathway
por: Zhang, Ying, et al.
Publicado: (2022)

Epigenetic Repression of RARRES1 Is Mediated by Methylation of a Proximal Promoter and a Loss of CTCF Binding
por: Peng, Zhengang, et al.
Publicado: (2012)

Evaluation of Bovine chemerin (RARRES2) Gene Variation on Beef Cattle Production Traits
por: Lindholm-Perry, Amanda K., et al.
Publicado: (2012)

Molecular evolution and expression profile of the chemerine encoding gene RARRES2 in baboon and chimpanzee
por: González-Alvarez, Rafael, et al.
Publicado: (2015)

Tumor suppressor RARRES1 links tubulin deglutamylation to mitochondrial metabolism and cell survival
por: Maimouni, Sara, et al.
Publicado: (2019)

2261 Tumor suppressor RARRES1 regulates cell survival by modulating mitochondrial energetics
por: Maimouni, Sara, et al.
Publicado: (2018)

GCH1 induces immunosuppression through metabolic reprogramming and IDO1 upregulation in triple-negative breast cancer
por: Wei, Jin-Li, et al.
Publicado: (2021)

Targeting copper death genotyping associated gene RARRES2 suppresses glioblastoma progression and macrophages infiltration
por: Yan, Tao, et al.
Publicado: (2023)

Myc derived circRNA promotes triple-negative breast cancer progression via reprogramming fatty acid metabolism
por: Wang, Shengting, et al.
Publicado: (2023)

CPSF4 promotes triple negative breast cancer metastasis by upregulating MDM4
por: Lee, Kaping, et al.
Publicado: (2021)

miR-136 suppresses tumor invasion and metastasis by targeting RASAL2 in triple-negative breast cancer
por: YAN, MEISI, et al.
Publicado: (2016)

Key Players in Choline Metabolic Reprograming in Triple-Negative Breast Cancer
por: Iorio, Egidio, et al.
Publicado: (2016)

MUC1 facilitates metabolomic reprogramming in triple-negative breast cancer
por: Goode, Gennifer, et al.
Publicado: (2017)

Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast Cancer
por: Munkácsy, Gyöngyi, et al.
Publicado: (2023)

Triple Negative Breast Cancer and Breast Epithelial Cells Differentially Reprogram Glucose and Lipid Metabolism upon Treatment with Triterpenic Acids
por: Guerra, Ângela R., et al.
Publicado: (2020)

Lipid metabolism reprogramming in head and neck cancer
por: Liang, Jinfeng, et al.
Publicado: (2023)

Tumor suppressor RARRES1- A novel regulator of fatty acid metabolism in epithelial cells
por: Maimouni, Sara, et al.
Publicado: (2018)

Correction: Tumor suppressor RARRES1 links tubulin deglutamylation to mitochondrial metabolism and cell survival
por: Maimouni, Sara, et al.
Publicado: (2021)

LIPG signaling promotes tumor initiation and metastasis of human basal-like triple-negative breast cancer
por: Lo, Pang-Kuo, et al.
Publicado: (2018)

ASMT Regulates Tumor Metastasis Through the Circadian Clock System in Triple-Negative Breast Cancer
por: Xie, FenFen, et al.
Publicado: (2020)

Ribosome Proteins Represented by RPL27A Mark the Development and Metastasis of Triple-Negative Breast Cancer in Mouse and Human
por: Zhao, Weipeng, et al.
Publicado: (2021)

Correction: MUC1 facilitates metabolomic reprogramming in triple-negative breast cancer
por: Goode, Gennifer, et al.
Publicado: (2017)

Histone H3K36me2 demethylase KDM2A promotes bladder cancer progression through epigenetically silencing RARRES3
por: Lu, Bing, et al.
Publicado: (2022)

Possible involvement of the RARRES2/CMKLR1-system in metabolic and reproductive parameters in Holstein dairy cows
por: Mellouk, Namya, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m5biph8rgejuuv85in14h351m2